BRUKER CORPORATION Litigation Settlement, Expense
BRUKER CORPORATION (BRKR) reported Litigation Settlement, Expense of $1.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2026-08-05
- BRUKER CORPORATION litigation settlement, expense for the quarter ending 2026-06-30 was $1.90M, a 52.50% decline year-over-year.
- BRUKER CORPORATION litigation settlement, expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION litigation settlement, expense for the quarter ending 2025-12-31 was $8.60M, a 75.00% decline year-over-year.
- BRUKER CORPORATION litigation settlement, expense for the quarter ending 2025-09-30 was $4.10M, a 54.44% decline year-over-year.
- BRUKER CORPORATION litigation settlement, expense for fiscal 2025 was $35.30M, a 21.38% decline from fiscal 2024.
- BRUKER CORPORATION litigation settlement, expense for fiscal 2024 was $44.90M.
- BRUKER CORPORATION litigation settlement, expense for fiscal 2023 was $0.00.
- BRUKER CORPORATION litigation settlement, expense for fiscal 2022 was $0.00.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.90M 10-Q · filed 2026-08-05 | $1.90M 10-Q · filed 2026-08-05 | $10.50M derived: sum of 3 quarters · filed 2026-08-05 | $14.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $8.60M derived: sum of 2 quarters · filed 2026-05-07 | $12.70M derived: sum of 3 quarters · filed 2026-05-07 | $16.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $12.70M derived: sum of 2 quarters · filed 2026-02-27 | $16.70M derived: sum of 3 quarters · filed 2026-08-05 | $35.30M 10-K · filed 2026-02-27 |
| 2025-09-30 | $4.10M 10-Q · filed 2025-11-05 | $8.10M derived: sum of 2 quarters · filed 2026-08-05 | $26.70M 10-Q · filed 2025-11-05 | $61.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $4.00M 10-Q · filed 2026-08-05 | $22.60M 10-Q · filed 2026-08-05 | $57.00M derived: sum of 3 quarters · filed 2026-08-05 | $66.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $18.60M 10-Q · filed 2026-05-07 | $53.00M derived: sum of 2 quarters · filed 2026-05-07 | $62.00M derived: sum of 3 quarters · filed 2026-05-07 | $63.40M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $34.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $43.40M derived: sum of 2 quarters · filed 2026-02-27 | $44.80M derived: sum of 3 quarters · filed 2026-02-27 | $44.90M 10-K · filed 2026-02-27 |
| 2024-09-30 | $9.00M 10-Q · filed 2025-11-05 | $10.40M derived: sum of 2 quarters · filed 2025-11-05 | $10.50M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $1.40M 10-Q · filed 2025-08-06 | $1.50M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |